These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 23694816)
21. Association of Impaired Cytochrome P450 2D6 Activity Genotype and Phenotype With Therapeutic Efficacy of Primaquine Treatment for Latent Plasmodium vivax Malaria. Baird JK; Louisa M; Noviyanti R; Ekawati L; Elyazar I; Subekti D; Chand K; Gayatri A; Instiaty ; Soebianto S; Crenna-Darusallam C; Djoko D; Hasto BD; Meriyenes D; Wesche D; Nelwan EJ; Sutanto I; Sudoyo H; Setiabudy R JAMA Netw Open; 2018 Aug; 1(4):e181449. PubMed ID: 30646129 [TBL] [Abstract][Full Text] [Related]
22. In-vivo sensitivity of Plasmodium vivax isolates from Rond nia (western Amazon region, Brazil) to regimens including chloroquine and primaquine. Villalobos-Salcedo JM; Tada MS; Kimura E; Menezes MJ; Pereira da Silva LH Ann Trop Med Parasitol; 2000 Dec; 94(8):749-58. PubMed ID: 11214093 [TBL] [Abstract][Full Text] [Related]
23. Effectiveness of an Unsupervised Primaquine Regimen for Preventing Plasmodium vivax Malaria Relapses in Northeast Myanmar: A Single-Arm Nonrandomized Observational Study. Malla P; Wang Z; Brashear A; Yang Z; Lo E; Baird K; Wang C; Cui L J Infect Dis; 2024 May; 229(5):1557-1564. PubMed ID: 38041857 [TBL] [Abstract][Full Text] [Related]
24. Polymorphism in merozoite surface protein-1 gene in north & northwest Indian field isolates of Plasmodium vivax. Farooq U; Malla N; Dubey ML Indian J Med Res; 2009 Dec; 130(6):736-41. PubMed ID: 20090136 [TBL] [Abstract][Full Text] [Related]
25. Diagnostic and therapeutic pitfalls associated with primaquine-tolerant Plasmodium vivax. Spudick JM; Garcia LS; Graham DM; Haake DA J Clin Microbiol; 2005 Feb; 43(2):978-81. PubMed ID: 15695723 [TBL] [Abstract][Full Text] [Related]
26. Primaquine for preventing relapses in people with Plasmodium vivax malaria. Galappaththy GN; Omari AA; Tharyan P Cochrane Database Syst Rev; 2007 Jan; (1):CD004389. PubMed ID: 17253504 [TBL] [Abstract][Full Text] [Related]
27. CYP2D6 activity and the risk of recurrence of Plasmodium vivax malaria in the Brazilian Amazon: a prospective cohort study. Brasil LW; Rodrigues-Soares F; Santoro AB; Almeida ACG; Kühn A; Ramasawmy R; Lacerda MVG; Monteiro WM; Suarez-Kurtz G Malar J; 2018 Feb; 17(1):57. PubMed ID: 29390987 [TBL] [Abstract][Full Text] [Related]
29. Assessment of therapeutic efficacy of chloroquine for vivax malaria in Thailand. Vijaykadga S; Rojanawatsirivej C; Congpoung K; Wilairatana P; Satimai W; Uaekowitchai C; Pumborplub B; Sittimongkol S; Pinyorattanachote A; Prigchoo P Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):566-9. PubMed ID: 15689067 [TBL] [Abstract][Full Text] [Related]
30. The use of ultrasensitive quantitative-PCR to assess the impact of primaquine on asymptomatic relapse of Plasmodium vivax infections: a randomized, controlled trial in Lao PDR. Phommasone K; van Leth F; Imwong M; Henriques G; Pongvongsa T; Adhikari B; Peto TJ; Promnarate C; Dhorda M; Sirithiranont P; Mukaka M; Peerawaranun P; Day NPJ; Cobelens F; Dondorp AM; Newton PN; White NJ; von Seidlein L; Mayxay M Malar J; 2020 Jan; 19(1):4. PubMed ID: 31900172 [TBL] [Abstract][Full Text] [Related]
31. Population genetic structure and polymorphism analysis of gene encoding apical membrane antigen-1 (AMA-1) of Iranian Plasmodium vivax wild isolates. Zakeri S; Sadeghi H; Mehrizi AA; Djadid ND Acta Trop; 2013 Jun; 126(3):269-79. PubMed ID: 23467011 [TBL] [Abstract][Full Text] [Related]
32. Chloroquine sensitivity of Plasmodium vivax in Thailand. Looareesuwan S; Wilairatana P; Krudsood S; Treeprasertsuk S; Singhasivanon P; Bussaratid V; Chokjindachai W; Viriyavejakul P; Chalermrut K; Walsh D S; White J Ann Trop Med Parasitol; 1999 Apr; 93(3):225-30. PubMed ID: 10562823 [TBL] [Abstract][Full Text] [Related]
34. Status of Plasmodium vivax malaria in the Republic of Korea, 2008-2009: decrease followed by resurgence. Yeom JS; Jun G; Kim JY; Lee WJ; Shin EH; Chang KS; Bang JH; Oh S; Kang JY; Park JW Trans R Soc Trop Med Hyg; 2012 Jul; 106(7):429-36. PubMed ID: 22560604 [TBL] [Abstract][Full Text] [Related]
35. Genetic analysis of primaquine tolerance in a patient with relapsing vivax malaria. Bright AT; Alenazi T; Shokoples S; Tarning J; Paganotti GM; White NJ; Houston S; Winzeler EA; Yanow SK Emerg Infect Dis; 2013 May; 19(5):802-5. PubMed ID: 23648098 [TBL] [Abstract][Full Text] [Related]
36. Recurrence rate of vivax malaria in the Republic of Korea. Moon KT; Kim YK; Ko DH; Park I; Shin DC; Kim C Trans R Soc Trop Med Hyg; 2009 Dec; 103(12):1245-9. PubMed ID: 19041109 [TBL] [Abstract][Full Text] [Related]
37. A local outbreak of autochthonous Plasmodium vivax malaria in Laconia, Greece--a re-emerging infection in the southern borders of Europe? Andriopoulos P; Economopoulou A; Spanakos G; Assimakopoulos G Int J Infect Dis; 2013 Feb; 17(2):e125-8. PubMed ID: 23098813 [TBL] [Abstract][Full Text] [Related]
38. Higher-Dose Primaquine to Prevent Relapse of Chamma-Siqueira NN; Negreiros SC; Ballard SB; Farias S; Silva SP; Chenet SM; Santos EJM; Pereira de Sena LW; Póvoa da Costa F; Cardoso-Mello AGN; Marchesini PB; Peterka CRL; Viana GMR; Macedo de Oliveira A N Engl J Med; 2022 Mar; 386(13):1244-1253. PubMed ID: 35353962 [TBL] [Abstract][Full Text] [Related]
39. Efficacy of Chloroquine and Primaquine for the Treatment of Uncomplicated Plasmodium vivax Malaria in Cruzeiro do Sul, Brazil. Negreiros S; Farias S; Viana GM; Okoth SA; Chenet SM; de Souza TM; Marchesini P; Udhayakumar V; Povoa MM; Santelli AC; de Oliveira AM Am J Trop Med Hyg; 2016 Nov; 95(5):1061-1068. PubMed ID: 27549633 [TBL] [Abstract][Full Text] [Related]
40. Relapse pattern of Plasmodium vivax in Mumbai: a study of 283 cases of vivax malaria. Khatri TD J Assoc Physicians India; 2002 Mar; 50():458-9. PubMed ID: 11922250 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]